• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

急性早幼粒细胞白血病的中枢神经系统受累：三例报告

Central nervous system involvement of acute promyelocytic leukemia, three case reports.

作者信息

Furuya Aya, Kawahara Masahiro, Kumode Mina, Ohira Yasuyuki, Usui Asako, Nagai Shiho, Hosoba Sakura, Minamiguchi Hitoshi, Kito Katsuyuki, Andoh Akira

机构信息

Division of Gastroenterology and Hematology Department of Medicine Shiga University of Medical Science Otsu Japan.

出版信息

Clin Case Rep. 2017 Mar 29;5(5):645-653. doi: 10.1002/ccr3.919. eCollection 2017 May.

DOI:10.1002/ccr3.919
PMID:28469869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5412762/
Abstract

Central nervous system (CNS) involvement of acute promyelocytic leukemia (APL) causes poor prognosis. Our three cases show that CNS can be involved at the first hematological recurrence, but predicting this is difficult. Triple intrathecal treatment and craniospinal irradiation were effective, while arsenic oxide failed to prevent and improve CNS involvement.

摘要

急性早幼粒细胞白血病（APL）累及中枢神经系统（CNS）会导致预后不良。我们的三例病例显示，CNS可在首次血液学复发时受累，但对此进行预测很困难。三联鞘内注射治疗和全脑全脊髓照射有效，而三氧化二砷未能预防和改善CNS受累情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3421/5412762/093688e9c388/CCR3-5-645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3421/5412762/bdd75f80c8fd/CCR3-5-645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3421/5412762/c3e1cd2c5235/CCR3-5-645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3421/5412762/093688e9c388/CCR3-5-645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3421/5412762/bdd75f80c8fd/CCR3-5-645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3421/5412762/c3e1cd2c5235/CCR3-5-645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3421/5412762/093688e9c388/CCR3-5-645-g003.jpg

相似文献

1
Central nervous system involvement of acute promyelocytic leukemia, three case reports.急性早幼粒细胞白血病的中枢神经系统受累：三例报告
Clin Case Rep. 2017 Mar 29;5(5):645-653. doi: 10.1002/ccr3.919. eCollection 2017 May.
2
Beneficial and adverse effects of molecularly targeted therapies for acute promyelocytic leukemia in central nervous system.急性早幼粒细胞白血病中枢神经系统中分子靶向治疗的有益和不良反应。
CNS Neurol Disord Drug Targets. 2009 Nov;8(5):387-92. doi: 10.2174/187152709789541943.
3
CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.全反式维甲酸治疗后急性早幼粒细胞白血病的中枢神经系统复发
Ann Pharmacother. 2002 Dec;36(12):1900-6. doi: 10.1345/aph.1A471.
4
The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.颅脑脊髓照射在成人白血病中枢神经系统复发中的作用。
Cancer. 2004 May 15;100(10):2176-80. doi: 10.1002/cncr.20280.
5
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.口服三氧化二砷为基础的再诱导和维持方案治疗复发急性早幼粒细胞白血病的长期疗效：一项 15 年的前瞻性研究。
Cancer. 2018 Jun 1;124(11):2316-2326. doi: 10.1002/cncr.31327. Epub 2018 Mar 26.
6
Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.西班牙急性白血病中枢神经系统预防与治疗实践。前瞻性注册研究。
Med Clin (Barc). 2008 Oct 4;131(11):401-5. doi: 10.1157/13126214.
7
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.三氧化二砷在治疗新诊断的急性早幼粒细胞白血病中是必需的。法国-比利时-瑞士 APL 组对一项随机试验（APL2006）的分析。
Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.
8
Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.三氧化二砷与全反式维甲酸（ATRA）治疗所有风险组急性早幼粒细胞白血病：一项随机对照试验的研究方案
Trials. 2018 Sep 5;19(1):476. doi: 10.1186/s13063-018-2812-3.
9
[Acute promyelocytic leukemia with central nervous system leukemia--a report of two cases].
Gan No Rinsho. 1988 Aug;34(9):1153-8.
10
Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement.一名接受三氧化二砷治疗复发的伴中枢神经系统受累的急性早幼粒细胞白血病患者脑脊液中的砷。
Leuk Res. 2007 Nov;31(11):1585-7. doi: 10.1016/j.leukres.2007.03.007. Epub 2007 Apr 9.

引用本文的文献

1
Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies.急性早幼粒细胞白血病：白血病发生、耐药机制及创新治疗策略的最新进展
Cancers (Basel). 2019 Oct 18;11(10):1591. doi: 10.3390/cancers11101591.
2
Intracranial acute promyelocytic leukemia at presentation-A case-based discussion.初诊时的颅内急性早幼粒细胞白血病——基于病例的讨论
Leuk Res Rep. 2019 May 2;11:41-45. doi: 10.1016/j.lrr.2019.04.007. eCollection 2019.

本文引用的文献

1
Tamibarotene as maintenance therapy for acute promyelocytic leukemia: results from a randomized controlled trial.他扎罗汀作为急性早幼粒细胞白血病维持治疗的疗效：一项随机对照试验的结果。
J Clin Oncol. 2014 Nov 20;32(33):3729-35. doi: 10.1200/JCO.2013.53.3570. Epub 2014 Sep 22.
2
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.AIDA 诱导后适应风险的巩固治疗用于年龄小于 61 岁的成人急性早幼粒细胞白血病的一线治疗：意大利血液与骨髓移植组 AIDA-2000 试验的结果。
Blood. 2010 Oct 28;116(17):3171-9. doi: 10.1182/blood-2010-03-276196. Epub 2010 Jul 19.
3
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.
接受全反式维甲酸和蒽环类单药化疗且未进行鞘内预防的急性早幼粒细胞白血病患者首次复发时的中枢神经系统受累情况。
Haematologica. 2009 Sep;94(9):1242-9. doi: 10.3324/haematol.2009.007872. Epub 2009 Jul 16.
4
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.急性早幼粒细胞白血病患者髓外疾病的发病率：单机构经验
Int J Hematol. 2009 May;89(4):489-496. doi: 10.1007/s12185-009-0291-8. Epub 2009 Apr 2.
5
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.急性早幼粒细胞白血病的管理：代表欧洲白血病网的专家小组建议
Blood. 2009 Feb 26;113(9):1875-91. doi: 10.1182/blood-2008-04-150250. Epub 2008 Sep 23.
6
Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy.接受口服三氧化二砷治疗的急性早幼粒细胞白血病患者脑脊液砷浓度的影响因素。
Blood. 2008 Nov 1;112(9):3587-90. doi: 10.1182/blood-2008-06-161000. Epub 2008 Aug 14.
7
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.新诊断急性早幼粒细胞白血病（APL）的治疗：法国-比利时-瑞士协作组与PETHEMA研究结果比较
Blood. 2008 Feb 1;111(3):1078-84. doi: 10.1182/blood-2007-07-099978. Epub 2007 Nov 1.
8
Treatment of relapsed or refractory acute promyelocytic leukemia.复发或难治性急性早幼粒细胞白血病的治疗。
Best Pract Res Clin Haematol. 2007 Mar;20(1):57-65. doi: 10.1016/j.beha.2006.11.002.
9
Extramedullary disease and targeted therapies for hematological malignancies--is the association real?
Ann Oncol. 2007 Jan;18(1):7-12. doi: 10.1093/annonc/mdl129. Epub 2006 Jun 21.
10
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.接受全反式维甲酸和化疗治疗的急性早幼粒细胞白血病髓外复发
Leukemia. 2006 Jan;20(1):35-41. doi: 10.1038/sj.leu.2404006.